Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 6 of 6 for “"TP508"”.
-
RADIOSENSITIZING EFFECTS OF THROMBIN PEPTIDE TP508 ON MEDULLOBLASTOMA CANCER STEM CELLS
… our laboratory showed that thrombin peptide TP508, a novel 23-amino acid investigational drug, protects normal neural stem cells from ionizing radiation damage. To determine whether the peptide would also protect brain CSCs from radiation damage, I examined the effects of TP508 on the …
-
TP508 maintains chondrocyte cell viability through blocking apoptosis in an NO-dependent manner
TP508 is a 23 amino acid peptide derived from human prothrombin. It helps wound healing in both soft tissues and bones. In our previous study, we have demonstrated that TP508 retains chondrocyte in a less mature differentiation state while expanding the cartilage mass, indicating it may partly help …
-
PEGylated Tissue Repair Peptide TP508 Derivatives as Second Generation Drugs for Radiomitigation and Other Systemic Applications
TP508 is a therapeutic peptide that represents a specific receptor-binding domain of human thrombin with many potential clinical applications. However, it shares several weaknesses common to peptides when administered systemically, such as a short circulating half-life and rapid proteolytic …
-
Insights into the mechanisms of wound repair and the role of TP508 in tissue regeneration
… adherens junctions and the tissue repair peptide TP508 as a potential modulator of inflammatory-induced endothelial activation. Second, these experiments aimed to determine how TP508 promoted dermal wound healing using two models of impaired dermal healing. To gain insights into the mediators of …
-
Targeted delivery of osteogenic drugs for bone tissue engineering
… experiment was conducted for native and modified TP508. Native and modified TP508 drugs were loaded in PLGA-PEG microparticles. Porous PPF scaffolds were injected with these drug-loaded particles, and in some instances with HA microparticles (20-50 or 50-100 mum). Less mineral surface resulted in …
-
Controlled release of osteogenic factors from injectable biodegradable composite materials for bone tissue engineering
… (PLGA) microparticles, the osteogenic peptide TP508 (Chrysalin RTM) was incorporated into the polymer phase of PPF-based scaffolds, creating a composite material that could act as a scaffold for guided tissue ingrowth as well as a vehicle for targeted drug delivery. Alteration of formulation …